9 Ankylosing Spondylitis Clinical Trials in Torrance, CA (2026)

Q: How do I join a clinical trial in Torrance?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Torrance research site will contact you.

Recruiting Ankylosing Spondylitis Studies in Torrance

NCT05946629Recruiting

SELUTION 4 De Novo Small Vessel IDE Trial

Prospective, randomized controlled, single-blind, multicenter, clinical trial to demonstrate the safety and efficacy of the SELUTION SLR 014 PTCA DEB for treatment of de novo lesions in small coronary...

Torrance, CANA960 participantsM.A. Med Alliance S.A.

View Study Details

NCT06937229Recruiting

A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3)

The purpose of this study is to evaluate the long-term efficacy and safety of combined formulation of xanomeline tartrate/trospium chloride in an immediate release (IR) capsule (KarXT) and xanomeline ...

Torrance, CAPHASE3650 participantsBristol-Myers Squibb

View Study Details

NCT07011732Recruiting

A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-1)

The purpose of this study is to evaluate the efficacy and safety of KarXT + KarX-EC in adult participants with agitation related to Alzheimer's Disease....

Torrance, CAPHASE3426 participantsBristol-Myers Squibb

View Study Details

NCT07503886Recruiting

An Exploratory Efficacy and Safety Study of DFL24498 Topical Ophthalmic Solution Compared With Vehicle in Participants With Dry Eye Disease

This is a Phase 2, randomized, multicenter, double masked, vehicle controlled, parallel group study to evaluate the efficacy and safety of DFL24498 topical ophthalmic solution versus vehicle in partic...

Torrance, CAPHASE2417 participantsDompé Farmaceutici S.p.A

View Study Details

NCT07682896Recruiting

Evaluation of YB-101 for Safety, Tolerability, Pharmacokinetics, and Efficacy in Graves' Disease

This study is being conducted to look at the effect YB-101 has on thyroid function. This study will also evaluate how safe and well tolerated YB-101 is and how it is distributed through the body. The...

Torrance, CAPHASE2232 participantsYarrow Bioscience, Inc.

View Study Details

NCT07303777Recruiting

Efficacy, Safety, and PopPK Profile of ABP-745 in Patients With Atherosclerosis

This is a multicenter, randomized, double-blind, placebo parallel controlled study to evaluate the preliminary efficacy, safety, and PopPK profile of ABP-745 in patients with ASCVD. Efficacy of ABP-74...

Torrance, CAPHASE2200 participantsAtom Therapeutics Co., Ltd

View Study Details

NCT07305818Recruiting

NEXUS Study: A Study to Test Single and Multiple Doses of MER511 Given to Adults With Graves' Disease

The purpose of this study is to evaluate how well MER511 is tolerated and what side effects may occur in adults who have Graves' disease. The study drug will be administered either intravenously (into...

Torrance, CAPHASE1100 participantsMerida Biosciences

View Study Details

NCT06954831Recruiting

Ultra-hypofractionated Whole Breast Irradiation With Lumpectomy Cavity Boost for the Treatment of Stage I-III Breast Cancer

This clinical trial tests how well ultra-hypofractionated (UF) whole breast irradiation (WBI) with lumpectomy cavity boost (CB) works in treating patients with stage I-III breast cancer. Breast conser...

Torrance, CAPHASE282 participantsCity of Hope Medical Center

View Study Details

NCT07017673Recruiting

Phase II Trial of Ivonescimab in Combination With Carboplatin + Docetaxel in Patients With Early-Stage Triple Negative Breast Cancer

This is a single arm phase II trial combination of ivonescimab and carbo-docetaxel every 3 weeks for 6 cycles in patients with early-stage triple negative breast cancer. The trial is designed to test ...

Torrance, CAPHASE234 participantsCedars-Sinai Medical Center

View Study Details

About Ankylosing Spondylitis Clinical Trials in Torrance

Ankylosing spondylitis is a chronic inflammatory disease primarily affecting the spine and sacroiliac joints, causing pain, stiffness, and potentially spinal fusion. It typically begins in early adulthood. Treatment includes NSAIDs, biologics (TNF and IL-17 inhibitors), and physical therapy.

There are currently 9 ankylosing spondylitis clinical trials recruiting participants in Torrance, CA. These studies are seeking a combined 3,101 participants. Research is being sponsored by M.A. Med Alliance S.A., Bristol-Myers Squibb, Dompé Farmaceutici S.p.A and 5 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Ankylosing Spondylitis Clinical Trials in Torrance — FAQ

Are there ankylosing spondylitis clinical trials in Torrance?

Yes, there are 9 ankylosing spondylitis clinical trials currently recruiting in Torrance, CA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Torrance?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Torrance research site will contact you about next steps.

Are clinical trials in Torrance free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Torrance studies also compensate for your time and travel.

What ankylosing spondylitis treatments are being tested?

The 9 active trials in Torrance are testing new therapies including novel drugs, biologics, and treatment approaches for ankylosing spondylitis.

Data updated September 2, 2026 from ClinicalTrials.gov